SEC Form 4 · accession 0001571049-15-007492

PHIBRO ANIMAL HEALTH CORP · PAHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Sep 8, 2015

Accepted (ET)

Sep 10, 2015 · 9:01 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001069899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock^F1	Sep 8, 2015	C	16,900	—	A	82,900	D
Class A Common Stock^F2,F3	Sep 8, 2015	S	6,000	$34.87	D	76,900	D
Class A Common Stock^F2,F4	Sep 9, 2015	S	6,000	$34.97	D	70,900	D
Class A Common Stock^F2,F5	Sep 10, 2015	S	6,000	$34.24	D	64,900	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Class B Common Stock^F1	—	Sep 8, 2015	C	16,900	D	—	—	Class A Common Stock	16,900	21,132,911	D

F1The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis, and had no expiration date.
F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2015.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.25 to $35.43, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.21 to $35.44, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.01 to $35.29, inclusive.